These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epigenetic regulation of airway inflammation. Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468 [Abstract] [Full Text] [Related]
3. Impact of protein acetylation in inflammatory lung diseases. Ito K, Charron CE, Adcock IM. Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252 [Abstract] [Full Text] [Related]
4. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? Grabiec AM, Tak PP, Reedquist KA. Arthritis Res Ther; 2008 Nov; 10(5):226. PubMed ID: 18983693 [Abstract] [Full Text] [Related]
8. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. N Engl J Med; 2005 May 12; 352(19):1967-76. PubMed ID: 15888697 [Abstract] [Full Text] [Related]
9. Epigenetics and chromatin remodeling play a role in lung disease. Mortaz E, Masjedi MR, Barnes PJ, Adcock IM. Tanaffos; 2011 May 12; 10(4):7-16. PubMed ID: 25191382 [Abstract] [Full Text] [Related]
10. Acetylation of Sirt2 by p300 attenuates its deacetylase activity. Han Y, Jin YH, Kim YJ, Kang BY, Choi HJ, Kim DW, Yeo CY, Lee KY. Biochem Biophys Res Commun; 2008 Oct 31; 375(4):576-80. PubMed ID: 18722353 [Abstract] [Full Text] [Related]
12. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Barnes PJ, Adcock IM, Ito K. Eur Respir J; 2005 Mar 31; 25(3):552-63. PubMed ID: 15738302 [Abstract] [Full Text] [Related]
13. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Barnes PJ. Proc Am Thorac Soc; 2009 Dec 31; 6(8):693-6. PubMed ID: 20008877 [Abstract] [Full Text] [Related]